Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04423679 | The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples(SELFIE) | completed | — | 294 | George Washington UniversityOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT05764005 | Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study | completed | N/A | 39 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 6, 2026 |
| clinicaltrials |
| NCT06184867 | Choices About Genetic Testing And Learning Your Risk With Smart Technology(CATALYST) | completed | N/A | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT00063882 | Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 588 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 5, 2026 | clinicaltrials |
| NCT05008900 | Timing of Post-prostatectomy PSMA Imaging(TOPP) | completed | Phase 2 | 4 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07448545 | Turkish Version of the UCLA Prostate Cancer Index | completed | — | 115 | Lokman Hekim UniversityOTHER_GOV | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04024254 | A Study of Serum Folate Levels in Patients Treated With Olaparib | completed | Phase 4 | 10 | Rush University Medical CenterOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT04288687 | A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects | completed | Phase 2 | 11 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT05035173 | The LYSA (Linking You to Support and Advice) Trial(LYSA) | completed | N/A | 200 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06472856 | Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer(VASA Pro) | completed | N/A | 12 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07450157 | A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617 | completed | — | 6,448 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 4, 2026 | clinicaltrials |
| NCT01409200 | Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis | completed | Phase 2 | 73 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT04443062 | Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer(Bullseye) | completed | Phase 2 | 58 | Radboud University Medical CenterOTHER | 2 | Feb 27, 2026 | clinicaltrials |
| NCT06056791 | Study of INKmune in Patients With mCRPC (CaRe Prostate)(CaRe) | completed | Phase 1 / Phase 2 | 12 | Inmune Bio, Inc.INDUSTRY | 1 | Feb 27, 2026 | clinicaltrials |
| NCT06624878 | Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer | completed | N/A | 568 | Zhejiang Cancer HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07439328 | ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer | completed | N/A | 30 | Institute of Oncology LjubljanaOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03159676 | Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | completed | — | 150 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT05968599 | A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer | completed | — | 2,731 | PfizerINDUSTRY | 1 | Feb 25, 2026 | clinicaltrials |
| NCT01314118 | IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen | completed | Phase 2 | 131 | Janssen Biotech, Inc.INDUSTRY | 1 | Feb 24, 2026 | clinicaltrials |
| NCT03568188 | Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer(FOCALE) | completed | Phase 2 | 174 | Hospices Civils de LyonOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT04697628 | Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer(innovaTV 301) | completed | Phase 3 | 502 | Seagen, a wholly owned subsidiary of PfizerINDUSTRY | 25 | Feb 24, 2026 | clinicaltrials |
| NCT06711380 | Patient Ambassador | completed | N/A | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT03005743 | Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial(COMBAT-Cx) | completed | N/A | 1,050 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 23, 2026 | clinicaltrials |
| NCT02899221 | Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation | completed | N/A | 3 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT04221945 | Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047) | completed | Phase 3 | 1,060 | Merck Sharp & Dohme LLCINDUSTRY | 30 | Feb 20, 2026 | clinicaltrials |
| NCT04806724 | Opening the Conversation Study | completed | N/A | 158 | Oregon State UniversityOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT00809991 | Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate | completed | Phase 2 | 91 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT04048252 | Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy(PROSTED) | completed | — | 18 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT06235099 | Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer(Solar-Recur) | completed | Phase 3 | 235 | Curium US LLCINDUSTRY | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07407179 | Quality of Life and Lymphedema After Surgical Treatment of Gynecological Malignancies | completed | N/A | 40 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07416812 | Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations(IMPACT) | completed | N/A | 25 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07417475 | Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction | completed | N/A | 200 | Araz MusaevOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT02776436 | Reducing Dexamethasone Around Docetaxel Infusion(REDEX) | completed | Phase 1 | 46 | Leiden University Medical CenterOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03421782 | Fatigue Interventions in Cancer (Exercise Intervention) | completed | Phase 2 | 126 | University of UtahOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06661902 | Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial(BURN) | completed | Phase 1 / Phase 2 | 350 | University of WashingtonOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07413120 | Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery | completed | Phase 3 | 40 | Incheon St.Mary's HospitalOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT01543659 | Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 77 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02274779 | Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer(OLIGOPELVIS) | completed | Phase 2 | 74 | Institut Cancerologie de l'OuestOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02313623 | MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research | completed | — | 600 | Yale UniversityOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT03995888 | Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer | completed | Phase 1 | 24 | Blue Earth DiagnosticsINDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT04662996 | Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs(MiR_CPMRC) | completed | N/A | 33 | University Hospital, ToursOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT01517451 | Radiation and Androgen Ablation for Prostate Cancer | completed | Phase 1 / Phase 2 | 45 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06253065 | Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer | completed | — | 225 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT03579394 | Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer(CHRONO) | completed | N/A | 211 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT05870787 | iMproving thE DIagnostics And Treatment Of ceRvical Precancer(MEDIATOR) | completed | — | 929 | University of AarhusOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT07393633 | Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy | completed | — | 43 | University of Tennessee Graduate School of MedicineOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT02195973 | Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer | completed | Phase 1 | 15 | University of Alabama at BirminghamOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT01113112 | Biobehavioral-Cytokine Interactions in Ovarian Cancer(VEGF) | completed | — | 613 | Susan LutgendorfOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT00893035 | Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients | completed | — | 885 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT02749110 | Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner(PaCUDAHL-Gé) | completed | N/A | 308 | University Hospital, LilleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Mar 6, 2026source: clinicaltrials